2005
Company Will Promptly and Fully Respond to FDA Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) announced today that it has received a warning letter from the U.S. Food and Drug Administration...
SPIRIT III U.S. Randomized Enrollment Passes Halfway Mark Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company has begun enrollment in the Japan arm of its SPIRIT...
Advanced Lead is Designed to Enable Physicians to Overcome Challenging Left Ventricular Anatomy Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT) today announced Conformité...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that its Board of Directors has made the requisite determination under Guidant's merger agreement with Johnson & Johnson to...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) acknowledges receipt of a letter dated today, , outlining a proposed transaction with Boston Scientific. Guidant's Board of Directors will...
Ronald W. Dollens Retires after 11 Years as CEO; Special Shareholder Meeting Anticipated in January Indianapolis, Ind. - In a joint press release issued earlier today, Guidant Corporation (NYSE:...
Results Demonstrate Sustained Benefit of the XIENCE V Everolimus Eluting Coronary Stent System Indianapolis, Ind., and Dallas, Texas - Guidant Corporation (NYSE: GDT) today announced 12-month...
Data from Study Will Support Launch of XIENCE V Coronary Stent System Outside the United States Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE: GDT) today announced that the company...
Cardiac Rhythm Management Report Delivers Unprecedented Level of Information Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) announced today the easy availability of even more detailed...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a fourth quarter dividend of $0.10 per share on outstanding common stock. This...
Design for Reliability Team Reflects Company Commitment to Quality Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced the establishment of an outside team of experts to point the...
Company Reports Third Quarter Sales of $795 Million Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, announced that it is...
Indianapolis, Ind. - We at Guidant Corporation (NYSE:GDT) take seriously the issues raised in the October 20 article in The New York Times titled: Behind Heart Implants, a History of Defects and a...
Transcript Now Available on Company Website Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) announced today that the Company has published its responses to the Form 483 observations issued by...
Innovative Wireless System Conveniently Monitors Device Status From the Comfort of the Patient''s Home Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced U.S....
Guidant-Supported Grant Honors Late Chief Medical Officer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that Dr. Giuseppe De Luca of Hospital De Weezenlanden, Zwolle, The...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it has received administrative subpoenas from the United States Department of Justice U. S. Attorney's offices in Boston...
Large-Scale Pivotal Trial to Evaluate Safety and Efficacy of Next-Generation XIENCE V Coronary Stent System Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company...
Study Suggests Therapy Can Be Performed Safely by Broad Group of Physicians Indianapolis, Ind. and Washington, D.C. - Guidant Corporation (NYSE: GDT) today announced preliminary results of its...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the Federal Trade Commission (FTC) has agreed to...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today responded to statements by Johnson & Johnson on its pending acquisition...
MULTI-LINK VISION® RX Coronary Stent System Provides Thin Struts, Superb Deliverability and Excellent Clinical Results Indianapolis, Ind. and Tokyo - Guidant Corporation (NYSE: GDT) today...
High Energy System Addresses Growing Physician Demand for More Defibrillation Energy Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today that it is informing physicians about two separate failure modes, each occurring at a low rate, being monitored within the...
Indianapolis, Ind. - Guidant announced today that the U.S. Food and Drug Administration (FDA) has completed its inspection of Guidant's Cardiac Rhythm Management facilities in St. Paul, Minnesota,...